biottechnogy

What we do

Partex.AI Therapeutics is developing innovative medicines based on a sophisticated artificial intelligence platform.

Partex.AI Therapeutics leverages artificial intelligence to identify the optimal applications of a given molecule and to de-risk clinical development.

Network-placeholder

Latest News

10 January 2025

CEO Mads Dalsgaard will be at JPM25 in San Francisco from 12-16 January – please reach out for meetings

Reach out directly or request meetings via the platform. Looking forward to interesting conversations on partnering and collaboration.

18 September 2024

Meet us at SACHS Biotech Conference, Basel 25-26 Sep 2024

Reach out directly or request meetings via the platform. Looking forward to interesting conversations on partnering and collaboration.

18 September 2024

Partex.AI Onco Therapeutics sponsor of Tiffany’s Pink Pedal Ride for Breast Cancer 2024

It was an honor for Partex.AI Onco Therapeutics to sponsor Tiffany’s Pink Pedal Ride, to raise money for breast cancer research and to commemorate Tiffany Lynn O’Donnell.

biottechnogy
ontosight ad illustration

Ontosight®

FREE for a limited time

Try now